Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anti-infective strategy is a major public health problem. This is a before-and-after study of an anti-infectious prescription tool with a comparison of mortality at 30 days (then 3 and 6 months) between the two inclusion phases of 6 months each.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 : Before | "Before" phase including 186 patients patients included before the implementation of the prescription support tool |
| |
| Group 2 : After | "After" phase including 185 patients patients included after the implementation of the prescription support tool |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Anti-infectious prescription support tool | Device | implementation of a pocket notebook with current anti-infectious recommendations in the emergency department Patients were kept under surveillance for at least one hour before discharge. Patients were discharged home with a 7 day supply of acetaminophen 1000 mg orally every 6 h, ketoprofen 100 mg, orally twice a day, and muscle relaxant as needed. Patients were instructed to take tramadol 50 mg, orally every 6h as needed for low back pain, in case of insufficient relief. |
| Measure | Description | Time Frame |
|---|---|---|
| Numbers of patient 30-day mortality | patient survival at 30 days | 30 day |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Numbers of patient 90-day mortality | patient survival at 90 days | 90 days |
| Numbers of patient 6 months mortality | patient survival at 6 months |
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Major patients with severe sepsis in the Montpellier emergency department
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hamza GHOMRANI, MD | University Hospital, Montpellier | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uh Montpellier | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 6 months |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |